Aseptic Pharma Processing Equipment Market Is Booming Worldwide Business Forecast 2027
Aseptic Pharma Processing Equipment Market Is Booming Worldwide Business Forecast 2027
The global aseptic pharma processing equipment market size is expected to grow from USD 4,543.5 million in 2020 to USD 7,456.8 million by 2027, at a CAGR of 7.2% from 2021 to 2027.


The global aseptic pharma processing equipment market size is expected to grow from USD 4,543.5 million in 2020 to USD 7,456.8 million by 2027, at a CAGR of 7.2% from 2021 to 2027. The manufacturing of pharmaceutical products requires high standards to ensure the strength of the active ingredients, purity, and quality of the final products. These standards ensure safe and efficient finished products for patients. Small changes in any of these factors can alter the overall composition and may have serious side effects. Thus, the checks and the controls which are applied need to be more stringent than the food industry.

Aseptic processing continues to be an essential method of manufacturing sterile biopharmaceutical products. Improvisation of aseptic processing is vital to achieving product quality, affordability, product availability, and patient health. The industry is lagging behind other industries in the use of new technologies to enable improvement. However, there are better ways to meet and address these challenges. To achieve the objective of aseptic process improvement, adopting new approaches to technology, process control strategies, and decision making plays a major role.

Conventional methods for validating, designing, operating, and monitoring aseptic pharma processing, need to be re-evaluated, modified, and replaced with new, more effective approaches if necessary. Proper process design and predictive process metrics should be the primary means to ensure product quality and process control, rather than a reliance on pass-fail test results and prescriptive limits. The growth and ideal use of technology to improve aseptic pharma processing will result from a collaborative effort of all key stakeholders.

Get a Sample PDF copy of the Report: -

COVID-19 Impact on the Global Aseptic Pharma Processing Equipment

The COVID-19 pandemic significantly impacted the global aseptic pharma processing equipment market. Manufacturers in different regions and local governments are increasingly seeking new approaches to address the situation. However, the manufacturing process has slowed down since the COVID-19 outbreak. The primary reason has been the difficulty in the supply of raw materials. The international trade was severely affected by the pandemic, but local manufacturers continued the operations.

The production of systems and consumables utilized in aseptic pharma processing equipment processes has been impacted by the COVID-19 scenario. Most of the companies focused on the development and approval of testing kits, rapid detection assays, and drugs or vaccines to reduce the impact of coronavirus. The majority of the OEMs and suppliers have reported declining their annual revenue in the FY2020 in their latest published annual report. However, the companies have managed to cope up with the situations by implementing proper guidelines and now delivering the purchase orders on time.

Global Aseptic Pharma Processing Equipment Market Dynamics

Drivers: High Growth in the Generics and Biopharmaceuticals Markets

The global aseptic pharma processing equipment market is expected to witness healthy growth in the coming years owing to rising healthcare spending, increasing prevalence of chronic diseases, and the introduction of novel drugs. Moreover, with the introduction of the COVID-19 pandemic, the demand for various generic drugs such as antibiotics, antivirals, steroids, and multivitamins has increased tenfold since 2020. This propels the pharma industries to increase production capacity within the current good manufacturing practices (cGMP) guidelines.

Many blockbuster drugs have also lost their patents in recent years, with more to follow in the coming years. This will permit the entry of low-cost generic counterparts in the market, which are likely to increase the volume of drugs sold. By the end of 2021, when patents for several prescription products expired in mature markets such as. the U.K. and the U.S., the overall sales of these drugs were set to abridge by more than hundreds of billion. However, the increase in sales volume is driven by growth in the generic and biopharmaceutical counterparts of the branded drugs. This growth in production volume is anticipated to drive the aseptic pharma processing equipment market for generic drug manufacturing, specifically in countries with low-cost manufacturing facilities across Asia-Pacific and Latin America. The growth in the demand for pharmaceutical drugs is projected to increase the need for efficient aseptic processing and packaging systems, which, in turn, will drive the market for advanced automated equipment to ensure high-speed packaging output.

Challenges: High Capital Investment

Setting up the aseptic pharma processing equipment is a one-time process with a shelf life of a minimum of 10 years. However, the equipment and systems cost is high, which restricts many pharmaceutical manufacturers from setting up an in-house aseptic pharma processing plant. Therefore, the high price of aseptic processing equipment determines many buyers and forces them to go with the conventional terminal sterilization method. This is expected to hamper the market growth for the aseptic pharma processing equipment market.

Opportunities: Increasing Investment in R&D

The high rise in the sales of pharmaceuticals has been witnessed in the last few years attributed to rising incidence of chronic disorders, growing geriatric population, high prevalence of infectious diseases, and increasing focus toward targeted therapy. The rising global demand for pharmaceuticals has fueled the growth of pharmaceutical products worldwide. Productivity improvement has been noticed in the pharmaceutical production industry, with an increase in research and clinical trials being conducted by pharmaceutical manufacturers. In addition, the outbreak of the COVID-19 pandemic has increased the focus of pharmaceutical companies to develop effective medicines and vaccines against the SARS-CoV virus infection. In this scenario, establishing effective processes and workflows to reduce the costs and time involved in drug and vaccine development has gained significance. This, in turn, is favoring the growth of the aseptic pharma processing equipment market.

Buy an exclusive copy: -

Scope of the Report

The study categorizes the aseptic pharma processing equipment market based on component, application, and region.

By Component Outlook (Sales, USD Million, 2017-2027)

  • Processing Equipment
  • Packaging Equipment

By Application Outlook (Sales, USD Million, 2017-2027)

  • Ophthalmic Suspensions
  • Sterile Injectables
  • Reconstituted Lyophilized
  • Powders for Injection
  • Aqueous-Based
  • Aerosols for Inhalation
  • Others

By Region Outlook (Sales, USD Million, 2017-2027)

  • North America (US, Canada, Mexico)
  • South America (Brazil, Argentina, Colombia, Peru, Rest of Latin America)
  • Europe (Germany, Italy, France, UK, Spain, Poland, Russia, Slovenia, Slovakia, Hungary, Czech Republic, Belgium, the Netherlands, Norway, Sweden, Denmark, Rest of Europe)
  • Asia Pacific (China, Japan, India, South Korea, Indonesia, Malaysia, Thailand, Vietnam, Myanmar, Cambodia, the Philippines, Singapore, Australia & New Zealand, Rest of Asia Pacific)
  • The Middle East & Africa (Saudi Arabia, UAE, South Africa, Northern Africa, Rest of MEA)

Processing equipment is accounted for the largest market in the global aseptic pharma processing equipment market by component

The global aseptic pharma processing equipment market has been divided into two basic categories packaging equipment and processing equipment. The aseptic processing equipment held the major share of around 57% in 2020, attributed to high demand and associated high cost per unit. The equipment is used to manufacture any drug (solid or liquid) in a sterile environment. Aseptic pharmaceutical processing is the process of drug manufacturing. It can be broken down into a range of unit operations, such as blending, granulation, milling, coating, tablet pressing, filling, and others. The aseptic pharmaceutical manufacturing process has precise requirements and manufacturing guidelines in terms of quality. As a result, pharmaceutical manufacturing companies must comply with good manufacturing practices. The equipment used for aseptic processing of pharmaceuticals is pharmaceutical drying equipment, pharmaceutical extruders, pharmaceutical mills, pharmaceutical granulation equipment, pharmaceutical tablet compression, pharmaceutical feeders, pharmaceutical filling equipment, pharmaceutical metal detection, pharmaceutical mixing equipment, pharmaceutical pneumatic conveying equipment.

Request for Report TOC, Table of Figure, Chart, etc:-

Asia Pacific accounts for the highest CAGR during the forecast period

The global aseptic pharma processing equipment market is segmented into five regions: North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. The Asia-Pacific region is expected to witness the fastest growth rate during the forecast period 2021-2027. The APAC region is expected to grow at a CAGR of 8.33% from 2021-2027. The Asia-Pacific (APAC) aseptic pharma processing equipment market is anticipated to grow rapidly in the forthcoming years. APAC is home to several countries, including China, Japan, India, Australia, Singapore, and South Korea, dedicated to research for the development of pharmaceuticals.

Asia-Pacific represents one of the most attractive markets worldwide for the aseptic pharma processing equipment market. It has the two most populous countries on its borders: China and India. The demographics and the accelerated economic growth in the region are the most supportive factors influencing the development of the Asia-Pacific aseptic pharma processing equipment market. Other prominent factors driving the growth of the Asia-Pacific aseptic pharma processing equipment market include rise in technological advancements, increasing investment in research and development, and availability of low-cost labor, which invites more investors to establish manufacturing units in the region. The region also marks the presence of some of the most developed nations in the world, including Japan, Australia, Hong Kong, and South Korea, among others. Furthermore, the developing economies of Singapore, India, Malaysia, and Australia offer lucrative market development opportunities. Most of the market growth achieved by these countries is through the adoption of accurate business strategies, market share gains, or the development of new product categories.

Key Market Players

The global aseptic pharma processing equipment market is largely dominated by companies such as GEA GA, AMCOR Limited, BOSCH GmbH, Industria Macchine Automatiche S.P.A., BD, SPX Flow, Inc., Du Pont, JBT, Rommelag Kunststoff-Maschinen Vertriebsgesellschaft mbH, Weiler Engineering, Inc, Steriline, Automated Systems of Tacoma (AST), and Greatview Aseptic Packaging Co., Ltd.

Recent Developments

  • In February 2021, Automated Systems of Tacoma, LLC (AST) and Goodwin Biotechnology, Inc. (Goodwin), a contract development and manufacturing organization (CDMO), underwent partnership on a Genisys C20 multi-format filling and closing machine for syringes, cartridges, and vials. Goodwin has purchased a GENiSYS C20 and Vial Sealing Module system, capable of automated cGMP aseptic small batch processing, and is collaborated with AST on its installation at its Plantation, Florida facility.
  • In March 2021, JBT Corporation acquired AutoCoding Systems Ltd., a leading provider of software solutions for the automated set-up and control of end-of-line packaging devices. AutoCoding extends JBT's capabilities in packaging line equipment and associated devices, including coding and labels inspection and verification.
  • In January 2019, Greatview underwent an agreement to acquire the entire equity interest in Qingdao Likang Food Packaging Technology Company Limited. Likang is based in Shandong Province, China, and its primary business is the production of aseptic packaging cartons for customers across China.
  • In May 2021, Amcor plc acquired Bemis Company Inc. to broaden its flexible and rigid packaging portfolio.

Key Issues Addressed

  • What is the market size by various segmentation of the aseptic pharma processing equipment by region and its respective countries?
  • What are the customer buying behavior, key takeaways, and Porter's 5 forces of the aseptic pharma processing equipment market?
  • What are the key opportunities and trends for manufacturers involved in the aseptic pharma processing equipment supply chain?
  • What are the fundamental dynamics (drivers, restraints, opportunities, and challenges) of the market?
  • What and how regulations, schemes, patents, and policies are impacting the growth of the market?
  • What are the upcoming technological solutions influencing market trends? How will existing companies adapt to the new change in technology?
  • The market player positioning, top winning strategies by years, company product developments, and launches will be?
  • How has COVID-19 impacted the demand and sales of aseptic pharma processing equipment in the global market? Also, the expected BPS drop or rise count of the market and market predicted recovery period.
  • Detailed analysis of the competitors and their latest launch, and what are the prominent startups introduced in the target market? Also, detailed company profiling of 25+ leading and prominent companies in the market.